These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3677442)
1. Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHR. Cohen ML; Kurz KD; Fuller RW Clin Exp Hypertens A; 1987; 9(10):1549-65. PubMed ID: 3677442 [TBL] [Abstract][Full Text] [Related]
2. mCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors. Robertson DW; Bloomquist W; Wong DT; Cohen ML Life Sci; 1992; 50(8):599-605. PubMed ID: 1736030 [TBL] [Abstract][Full Text] [Related]
3. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat. Cohen ML; Fuller RW; Kurz KD J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898 [TBL] [Abstract][Full Text] [Related]
4. Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion. Ulrichsen J; Partilla JS; Dax EM Psychopharmacology (Berl); 1992; 107(2-3):229-35. PubMed ID: 1352053 [TBL] [Abstract][Full Text] [Related]
5. [The effect of the flesinoxan subtype of serotonin C1a receptor agonist on the arterial pressure in rats]. Piianzin AI; Popova NK; Markel' AL Farmakol Toksikol; 1991; 54(4):28-30. PubMed ID: 1786817 [TBL] [Abstract][Full Text] [Related]
6. Time courses of behavioral and regional cerebral metabolic responses to different doses of meta-chlorophenylpiperazine in awake rats. Freo U; Soncrant TT; Ricchieri GL; Wozniak KM; Larson DM; Rapoport SI Brain Res; 1990 Mar; 511(2):209-16. PubMed ID: 2334843 [TBL] [Abstract][Full Text] [Related]
7. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men. Meltzer HY; Maes M Psychiatry Res; 1995 Sep; 58(2):89-98. PubMed ID: 8570772 [TBL] [Abstract][Full Text] [Related]
8. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine. Fiorella D; Rabin RA; Winter JC Psychopharmacology (Berl); 1995 May; 119(2):222-30. PubMed ID: 7659770 [TBL] [Abstract][Full Text] [Related]
9. Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects. Seibyl JP; Krystal JH; Price LH; Woods SW; D'Amico C; Heninger GR; Charney DS Psychiatry Res; 1991 Sep; 38(3):227-36. PubMed ID: 1754635 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive effects of chronic 5-hydroxytryptamine (5-HT2) receptor blockade with irindalone in the spontaneously hypertensive rat. Gradin K; Hedner T; Persson B J Neural Transm Gen Sect; 1991; 83(3):227-33. PubMed ID: 1674420 [TBL] [Abstract][Full Text] [Related]
13. Effect of the activation of central 5-HT2C receptors by the 5-HT2C agonist mCPP on blood pressure and heart rate in rats. Ferreira HS; Oliveira E; Faustino TN; Silva Ede C; Fregoneze JB Brain Res; 2005 Apr; 1040(1-2):64-72. PubMed ID: 15804427 [TBL] [Abstract][Full Text] [Related]
14. Cerebral metabolic responses to meta-chlorophenylpiperazine are reduced during its chronic administration to young and aged rats. Freo U; Larson DM; Soncrant TT Gerontology; 1993; 39(6):305-13. PubMed ID: 8144044 [TBL] [Abstract][Full Text] [Related]
15. Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents. Ghaziuddin N; Welch K; Greden J Neuropsychopharmacology; 2003 Jan; 28(1):133-9. PubMed ID: 12496949 [TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine and behavioral effects of m-chlorophenylpiperazine administration in rhesus monkeys. Aloi JA; Insel TR; Mueller EA; Murphy DL Life Sci; 1984 Apr; 34(14):1325-31. PubMed ID: 6708733 [TBL] [Abstract][Full Text] [Related]
17. Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects. Kahn RS; Kalus O; Wetzler S; Cahn W; Asnis GM; van Praag HM Psychiatry Res; 1990 Aug; 33(2):189-98. PubMed ID: 2243896 [TBL] [Abstract][Full Text] [Related]
18. Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats. Aulakh CS; Wozniak KM; Hill JL; Devane CL; Tolliver TJ; Murphy DL Neuroendocrinology; 1988 Oct; 48(4):401-6. PubMed ID: 2463494 [TBL] [Abstract][Full Text] [Related]
19. M-chlorophenylpiperazine increases blood pressure and heart rate in pithed and conscious rats. Bagdy G; Szemeredi K; Zukowska-Grojec Z; Hill J; Murphy DL Life Sci; 1987 Aug; 41(6):775-82. PubMed ID: 3112482 [TBL] [Abstract][Full Text] [Related]
20. Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67. Fuller RW; Kurz KD; Mason NR; Cohen ML Eur J Pharmacol; 1986 Jun; 125(1):71-7. PubMed ID: 3732393 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]